Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations

Completed · Phase 4

Conditions studied: Cryptogenic Sensory Polyneuropathy

In brief

The purpose of this large comparative effectiveness study led by Richard J. Barohn, MD, of the University of Kansas Medical Center, is to learn about the safety and effectiveness of nortriptyline, duloxetine, pregabalin and mexiletine in treating cryptogenic sensory polyneuropathy (CSPN).

Key facts

Study ID
NCT02260388
Run by
University of Kansas Medical Center
People needed
402
Starts
2014-10-01
Expected to finish
2017-09-01
Last updated by the study team
2018-07-06

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.